[ad_1]
In a phase 3 study of 2,260 adolescents in the United States, “100% efficacy and a strong antibody response,” the company said in a statement.
This report, released Wednesday, is a step that could bring us closer to vaccinating this age group before the next school year.
Most COVID-19 vaccines are used to vaccinate adults who are at higher risk. The Pfizer vaccine is approved for use in people 16 years of age and older, but vaccinating children of all ages would be very effective in stopping the pandemic.
Pfizer and its partner, the German company BioNTech, plan to apply to the US Food and Drug Administration and the European Medicines Agency in the coming weeks for permission to use the vaccine in an emergency for children 12 years and older. It is expected that in the near future, research will be conducted in the US on the use of Moderna in people 12 to 17 years of age.
In the United States, 13 percent of children are diagnosed. of all COVID-19 cases registered in the country.
